Open AccessThree-way, three-period, crossover bioequivalence study of single oral dose of three brands of 300 mg phenytoin sodium tablets marketed in India, on healthy Indian human volunteers
Author(s) -
Maulik Doshi,
Anuja Naik,
Mohit R Mehta,
Nithya J Gogtay,
Urmila M Thatte,
Mala Me
Publication year - 2013
Publication title -
journal of pharmacology and pharmacotherapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.301
H-Index - 34
eISSN - 0976-5018
pISSN - 0976-500X
DOI - 10.4103/0976-500x.119709
Subject(s) - bioequivalence , cmax , medicine , crossover study , bioavailability , confidence interval , phenytoin , pharmacokinetics , pharmacology , anesthesia , epilepsy , placebo , alternative medicine , pathology , psychiatry
To compare the bioavailability of two brands of phenytoin sodium tablets available in the Indian market using Eptoin™ as the reference.